Trial · NCT07301138
BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients
NCT07301138, Phase 2, Not yet recruiting, Ruijin Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients. Trials, record NCT07301138. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07301138
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients
- NCT number
- NCT07301138
- Status
- Not yet recruiting
- Phases
- Phase 2
- Enrollment
- 23 participants, estimated
- Lead sponsor
- Ruijin Hospital
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- BEBT-908, Cyclophosphamide, Vincristine, Dexamethasone, Methotrexate, Cytarabine
- First posted
- 2025-12-24
- Last updated
- 2025-12-24
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | MRD negativity rate | At the end of Cycle 2 of BEBT-908 combined chemotherapy treatment (each cycle is 28 days) | The proportion of patients who reach MRD negative |
| Secondary | Overall survival (OS) | up to 24 months | Interval from the date of the feedback to the time of death due to any reason |
| Secondary | Relapse-free survival (RFS) | up to 24 months | Interval from the date of BEBT-908 treatment to the time of diagnosis of hematological recurrence or death from any cause |
| Secondary | Progression-Free Survival (PFS) | up to 24 months | Interval from the date of BEBT-908 treatment to the time of diagnosis of disease progression or death from any cause |
| Secondary | Incidence of adverse events | up to 24 months | The proportion of patients who have adverse events after BEBT-908 treatment |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07301138
GET https://conductscience.org/api/trials/v1/NCT07301138/registered